ANAPHYLAXIS IN COMMON VARIABLE IMMUNODEFICIENCY PATIENT AFTER TRANSITIONING FROM INTRAVENOUS TO SUBCUTANEOUS IMMUNOGLOBULIN

Pham S.; Jones E.; Banka L.; Li M.; Kwong K.; Scott L.

首页> 外文期刊>Annals of allergy, asthma, and immunology >ANAPHYLAXIS IN COMMON VARIABLE IMMUNODEFICIENCY PATIENT AFTER TRANSITIONING FROM INTRAVENOUS TO SUBCUTANEOUS IMMUNOGLOBULIN

【24h】

ANAPHYLAXIS IN COMMON VARIABLE IMMUNODEFICIENCY PATIENT AFTER TRANSITIONING FROM INTRAVENOUS TO SUBCUTANEOUS IMMUNOGLOBULIN

机译：在静脉内静脉内静脉内免疫接种免疫球蛋白过渡后，常见可变免疫缺陷患者的过敏反应

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of allergy, asthma, and immunology 》 |2019年第1期| 共3页
作者
Pham S.; Jones E.; Banka L.; Li M.; Kwong K.; Scott L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学 ;
关键词

相似文献

外文文献
中文文献
专利

1. ANAPHYLAXIS IN COMMON VARIABLE IMMUNODEFICIENCY PATIENT AFTER TRANSITIONING FROM INTRAVENOUS TO SUBCUTANEOUS IMMUNOGLOBULIN [J] . Pham S., Jones E., Banka L., Annals of allergy, asthma, and immunology . 2019 ,第5Suppla1期

机译：在静脉内静脉内静脉内免疫接种免疫球蛋白过渡后，常见可变免疫缺陷患者的过敏反应
2. Anaphylaxis to IGIV in immunoglobulin-na?ve common variable immunodeficiency patient in the absence of IgG anti-IgA antibodies: successful administration of low IgA-containing immunoglobulin [J] . Asal Gharib, Caroline Caperton, Sudhir Gupta Allergy, Asthma & Clinical Immunology . 2016 ,第1期

机译：在缺乏IgG抗IgA抗体的情况下，对初次免疫球蛋白的普通可变免疫缺陷患者进行IGIV的过敏反应：成功给予低IgA的免疫球蛋白
3. Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy [J] . Krishnarajah Girishanthy, Lehmann Jee-Yeon K., Ellman Brian, The American journal of managed care . 2016 ,第15Suppla期

机译：评价原发性免疫缺陷疾病患者转皮下免疫球蛋白治疗比例为20％的患者皮下与静脉免疫球蛋白治疗的剂量比
4. Standards of treatment with subcutaneous immunoglobulins in primary immunodeficiencies –guidelines for doctors and nurses drawn up by three immunology centers in Poland. [C] . Lewowicz-Uszyńska A., Szaflarska A., Pietrucha B., European Society Immunodeficiencies., Meeting. . 2013

机译：初级免疫植物中皮下免疫球蛋白的治疗标准 - 在波兰三次免疫中心制定的医生和护士。
5. The Role of Illness Intrusiveness and Personal Control in Mediating the Relationship between the Intravenous Immunoglobulin Treatment Experience and Quality of Life in Neurological Autoimmune Patients. [D] . Gennari, Pamela Jane. 2016

机译：疾病侵入性和个人控制在介导神经系统自身免疫性患者静脉免疫球蛋白治疗经验与生活质量之间的关系中的作用。
6. Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia? [O] . Philipp Scheuerlein, Larissa Pietsch, Nadezhda Camacho-Ordonez, -1

机译：对于常见可变免疫功能低下和自身免疫性血小板减少症的患者从静脉免疫球蛋白转换为皮下免疫球蛋白是否安全？
7. Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia? [O] . Philipp Scheuerlein, Larissa Pietsch, Nadezhda Camacho-Ordonez, 2018

机译：是否可以安全地从常见的可变免疫缺陷和自身免疫血小板减少症患者皮下免疫球蛋白从静脉内免疫球蛋白转换为皮下免疫球蛋白？

ANAPHYLAXIS IN COMMON VARIABLE IMMUNODEFICIENCY PATIENT AFTER TRANSITIONING FROM INTRAVENOUS TO SUBCUTANEOUS IMMUNOGLOBULIN

著录项

相似文献

相关主题

期刊订阅